Wisconsin SB 1032: Relating to: prescription drug cost reporting by manufacturers and providing a penalty.

Status: Failed to pass pursuant to Senate Joint Resolution 1 (as of 2024-04-15)

State: Wisconsin · Session: 2023 · Bill: SB 1032

Sponsors: Agard, Carpenter, Pfaff, Roys, Spreitzer

View Wisconsin SB 1032 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.